169166 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites
NEW LACTIC ACID BACTERIA
#2SYSTEM AND METHOD OF IDENTIFICATION OF A SPECIFIC ALKYLAMIDE FOR THE TREATMENT OF RESPIRATORY VIRUS INFECTIONS
#3COMPOSITIONS AND METHODS TARGETING SWIP-10 AND MBLAC1 FOR THE THERAPEUTIC MODULATION OF COPPER DYSHOMEOSTASIS
#4COMPOUNDS FOR TARGETED PROTEIN DEGRADATION
#5METHODS OF ASSESSING METABOLIC FLUX
#6METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE
#7METHODS OF IDENTIFYING SELECTIVE CONDENSATE MODULATORS
#8STRUCTURE-BASED DESIGN OF A NOVEL CLASS OF DRUGS FOR NEURODEGENERATIVE DISEASE
#9CALIBRATING AND NORMALIZING AN IMAGER FOR OPTOGENETICS
#10HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE
#11METHODS OF OPTIMIZING KINASE INHIBITORS
#12FLUOROMETRIC METHODS FOR DETECTION OF ALLERGIC SENSITIVITY TO ENVIRONMENTAL, FOODSTUFF, AND MEDICAMENT STIMULANTS
#13ENGINEERING CHEMICALLY INDUCIBLE SPLIT PROTEIN ACTUATORS (CISPA)
#14COMPOSITIONS AND METHODS FOR TREATING PSEUDOMYXOMA PERITONEI
#15METHODS FOR IDENTIFYING THERAPEUTIC AGENTS
#16OSTEOPOROSIS MODEL COMPRISING CALCIUM PHOSPHATE HYDROGEL COMPOSITION AND USE THEREOF
#17SYSTEM TO CALCULATE HUMAN ORAL BIOAVAILABILITY
#18METHODS AND USES OF MICROBIOME COMPOSITIONS
#19METHODS FOR PREDICTING AUTOIMMUNITY POST GENE THERAPY
#20SYSTEMS AND METHODS FOR ASSAYING SECRETOME
#21RNA SEQUENCES THAT INDUCE FLUORESCENCE OF SMALL MOLECULE FLUOROPHORES, MOLECULAR COMPLEXES, SENSORS, AND METHODS OF USE THEREOF
#22Discovering Active Components in Herbals by Manipulating Common Elements
#23PLATFORMS FOR DRUG TESTS AGAINST SYNUCLEINOPATHY USING HUMAN BRAIN ORGANOIDS
#24METHODS AND MATERIALS FOR DETERMINING pGC TARGET DOSAGE
#25COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#26METHODS OF SCREENING INHIBITORS OF BIOMOLECULAR INTERACTIONS USING PHASE SEPARATION AS IN CELLULO READ-OUT
#27NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE
#28MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#29CELLULAR SELECTIVITY PROFILING AGAINST RNA HELICASES AND SPLICING REGULATORS
#30HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE
#31METHOD FOR PRODUCING BRAIN ORGANOID INCLUDING AGGREGATED TAU PROTEIN
#32MULTI-ORGAN MODEL
#33NOVEL METHOD FOR POOLED INTRON TAGGING FOR REAL TIME DRUG SCREENING
#34COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF COMPOUNDS THAT PROTECT AGAINST LIPOFUSCIN CYTOTOXICITY
#35METHOD FOR IDENTIFYING AND/OR FOR OBTAINING AN ACTIVE SUBSTANCE FOR THE TREATMENT AND THERAPY OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS, AND USE OF AN ACTIVE SUBSTANCE FOR THE TREATMENT OF THIS DISEASE
#36SPECIFIC SUBSTRATES AND PRODUCTS OF HSD17B13 AS MARKERS OF LIVER DISEASE AND BIOMARKERS FOR LIVER DISEASE TREATMENT
#37DEVICES AND METHODS FOR MONITORING CELLS, TISSUES, OR ORGANS-ON-A-CHIP
#38Novel Compounds
#39High Throughput Multiparametric Immune Cell Engager Screening Assay
#40Systems, Devices And Methods For Cell Analysis Using ChemFET Sensor Arrays
#41REACTIVE AFFINITY PROBE-INTERACTION DISCOVERY PLATFORM
#42HIGH-COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES
#43DISEASE REPRESENTATION AND CLASSIFICATION WITH MACHINE LEARNING
#44METHOD FOR EVALUATING THE METABOLIC ACTIVITY OF A NON-CANCER CELL
#45METHODS AND DEVICES FOR CELL BASED ASSAYS
#46Immune Response Suppressor
#47COMPOSITIONS AND METHODS FOR DIABETES TREATMENT
#48FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS
#49BIOMARKER TESTING AND DIAGNOSTICS
#50METHODS AND SYSTEMS FOR DETERMINING METABOLIC POISE AND CAPACITY OF LIVING CELLS
#51Hyperspectral imaging for early detection of Alzheimer's disease
#52DISEASE DETECTION AND TREATMENT BASED ON PHENYLACETYL GLUTAMINE LEVELS
#53Biomarkers and uses thereof
#54METHOD FOR EVALUATING SAFETY OF SUBSTANCE IN VITRO USING HUMAN IMMORTALIZED MYELOID CELLS
#55IN VITRO DRUG METABOLISM REAGENT AND USES THEREOF
#56COMPOSITIONS, SYSTEMS, AND METHODS FOR IDENTIFYING A COMPOUND THAT MODULATES ONE OR MORE CHARACTERISTICS ASSOCIATED WITH A RBM20 CONDENSATE AND/OR A RBM20 POLYPEPTIDE
#57Spectographic Metabolite-Signature for Identifying a Subject's Susceptibility to Drugs
#58SCREENING METHOD FOR APP CLEAVAGE ACTIVITY-CONTROLLING SUBSTANCES OF ADAMTS4
#59METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE
#60Method To Evaluate Metabolic Activity Of Liver Enzymes
#61CULTURE APPARATUS FOR DRUG DISCOVERY RESEARCH
#62CALIBRATING AND NORMALIZING AN IMAGER FOR OPTOGENETICS
#63METHODS AND SYSTEMS FOR EVALUATION OF CELL SAMPLES
#64NEW LACTIC ACID BACTERIA
#65SELECTION OF T CELL RECEPTORS
#66Osteoporosis model comprising calcium phosphate hydrogel composition and use thereof
#67GRAVITY FLOW MICRO-PHYSIOLOGICAL ARTICLE AND DETERMINING A PHYSIOLOGICAL RESPONSE TO A DRUG
#68PRODUCE AND ISOLATE AND/OR EXTRACT COLLAGEN AND/OR GELATIN FROM ANIMAL CELL LINES AND/OR TISSUE EXPLANTS
#69METHODS AND USES OF MICROBIOME COMPOSITIONS
#70METHODS OF TREATING NEURODEGENERATIVE DISEASES BY TARGETING THE PURINERGIC AND/OR ADENOSINE RECEPTORS
#71GENETIC ABNORMALITIES IN PLASMA CELL DYSCRASIAS
#72METHOD FOR DETECTING ALLERGIC DISEASES
#73IN VITRO MODEL OF LIVER STEATOSIS AND FIBROSING NON-ALCOHOLIC STEATOHEPATITIS
#74Hyperspectral imaging for detection of transmissible spongiform encephalopathy
#75Detection and modification of gut microbial population
#76Methods of making hydraulic fracturing fluids and use thereof
#77MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#78Nano-enzyme containers for test elements
#79INTEGRATED DRUG DISCOVERY PLATFORM FOR INBORN ERROR OF METABOLISM DISORDERS
#80Detection and modification of gut microbial population
#81Metabolic profiling by reverse-phase/ion-exchange mass spectrometry
#82Detection and modification of gut microbial population
#83Detection and modification of gut microbial population
#84IMMUNE FUNCTION INSPECTION METHOD, CANCER PATIENT CATEGORIZATION METHOD, CANCER TREATMENT EFFICACY PREDICTION METHOD, AGENT FOR INCREASING INTRACELLULAR CALCIUM ION CONCENTRATION, AGENT FOR INCREASING SELECTIVE FUNCTION OF EFFECTOR MEMORY (EM) AND EFFECTOR (EFF) IN TUMOR TISSUE, AND METHOD FOR MONITORING EFFICACY OF CANCER DRUG
#85COMPOSITION
#86Method for detecting human ingested substance and ingestion times
#87METHODS FOR IDENTIFYING THERAPEUTIC AGENTS WHICH INTERACT WITH STK24
#88Biomarkers for age-related macular degeneration
#89Methods for treating wild type isocitrate dehydrogenase 1 cancers
#90Device for rapid detection of tuberculosis-lipoarabinomannan (TB-LAM) with enhanced sensitivity
#91FUNCTIONAL LIGANDS TO OPIOIDS AND OPIOID METABOLITES
#92Method for measuring cholesterol uptake capacity of lipoproteins
#93PLATFORM FOR EARLY DETECTION OF PATHOGEN INFECTION
#94BIOLOGICAL MATERIALS AND USES THEREOF
#95Detection of analytes using live cells
#96ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#97SENSORS COMPRISING MESOPOROUS SILICA PARTICLES
#98SYSTEM AND METHOD FOR DETECTING THERAPEUTIC AGENTS TO MONITOR ADHERENCE TO A TREATMENT REGIMEN
#99TEMOZOLOMIDE RESISTANT CELLS AND AN INTEGRATED METHOD FOR CHARACTERIZING THE SAME
#100METHODS FOR IDENTIFYING THERAPEUTIC AGENTS WHICH INTERACT WITH STK24
#101Method, composition and kit for screening ALK or ROS-1 kinase inhibitor
#102Spectographic metabolite-signature for identifying a subject's susceptibility to drugs
#103METHOD FOR MEASURING CARBOHYDRATE METABOLISM ABILITY, AND COMPOSITION FOR USE IN SAID METHOD
#104Method for rapid identification of pharmacologically active chemical entities associated with the efficacy of ethnobotanical substances
#105Well plate cover with embedded electronic sensors for monitoring cell metabolism
#106Non-human animals having a humanized programmed cell death 1 gene
#107Compounds and methods for inhibiting phosphate transport
#108Monitoring cancer recurrence and progression
#109Regulation of glucose metabolism using anti-CGRP antibodies
#110METHODS FOR DRUG DISCOVERY USING STEM CELL-DERIVED SCHWANN CELLS
#111Method of evaluating hepatic glucose uptake capacity
#112METHOD FOR DETERMINING ALZHEIMER'S DISEASE RISK
#113STEM CELL-DERIVED SCHWANN CELLS
#114Methods and systems for detecting bioanalytes
#115Screening methods using olfactory receptors and novel compounds identified using the same
#116Device for rapid detection of tuberculosis-lipoarabinomannan (TB-LAM) with enhanced sensitivity
#117METHOD TO MEASURE RELATIVE UTILIZATION OF AEROBIC GLYCOLYSIS BY POSITIONAL ISOTOPIC DISCRIMINATION
#118Hyperspectral imaging for detection of Alzheimer's disease
#119BIOMARKERS FOR THE DIAGNOSIS OF INFLAMMATION-RELATED DISEASES
#120Physiologic insulin-sensitivity improvement
#121SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGETED CHALLENGE AND IDENTIFICATION OF GUT MICROBIOTA
#122Niacinamide (NAM) in ischemic tissue injury
#123SYSTEM AND METHOD FOR DETECTING THERAPEUTIC AGENTS TO MONITOR ADHERENCE TO A TREATMENT REGIMEN
#124BIOLOGICAL MATERIALS AND USES THEREOF
#125A METHOD OF NON DESTRUCTIVE MONITORING OF BIOLOGICAL PROCESSES IN MICROFLUIDIC TISSUE CULTURE SYSTEMS
#126Soluble MANF in pancreatic beta-cell disorders
#127Methods and compositions for treating metabolic imbalance in neurodegenerative disease
#128Genetic abnormalities in plasma cell dyscrasias
#129Method of osteogenic differentiation in microfluidic tissue culture systems
#130Method for the early detection of acute kidney injury in critical patients, using fibroblast growth factor 23, klotho and erythropoietin as biomarkers
#131Gradient-on-a-chip
#132Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction
#133Method of osteogenic differentiation in microfluidic tissue culture systems
#134Method for detecting oxidising species
#135NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE
#136Nano-enzyme containers for test elements
#137BIOMARKERS FOR PREDICTION OF DEVELOPMENT OF HYPOXEMIA DUE TO ACUTE LUNG INJURY
#138Characterization of Type 1 Collagen Synthesis By Fluorescence Imaging and Related Drug Screening Technique
#139Method for evaluating and selecting agent for suppressing odors of sulfide compounds
#140Metabolic pathway and metabolite identification
#141NMR-BASED METABOLITE SCREENING PLATFORM
#142Structural elucidation of isotopically labeled analytes
#143Biosensors for detecting cholesterol and OxLDL in blood sample
#144IN VITRO DRUG METABOLISM REAGENT AND USES THEREOF
#145Universal antibody-mediated biosensor
#146Methods and systems for biomonitoring
#147METHODS OF MONITORING AND ANALYZING METABOLIC ACTIVITY PROFILES DIAGNOSTIC AND THERAPEUTIC USES OF SAME
#148Biological Materials and Uses Thereof
#149Method for selecting patients responsive for cancer treatments
#150Method and system for identification of metabolites using mass spectra
#151Phenotypic High-Content Assay to Evaluate Drugs
#152Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#153System and method for locally correlated spectroscopy for assessing medical discorders
#154Detection of analytes using live cells
#155Methods and compositions for treating skin to resolve inflammation and screening for actives that stimulate pro-resolution pathways
#156Method for measuring cholesterol uptake capacity of lipoproteins
#157Neuroprotective Chemicals and Methods for Identifying and Using Same
#158Methods and assays relating to sepiapterin reductase inhibition
#159Method of identifying or evaluating synergistic combinations of actives and compositions containing the same
#160DEVICE FOR HOLDING AN INDICATOR
#161METHODS FOR IDENTIFYING COMPOUNDS THAT ALTER THE ACTIVITY OF IRHOM POLYPEPTIDES AND USE THEREOF
#162BENZOTHIOPHENE, BENZYLOXYBENZYLIDENE AND INDOLINE DERIVATIVES USEFUL FOR THE TREATMENT OF TUBERCULOSIS
#163Substrate clearance assays for lysosomal enzymes
#164REGULATION OF GLUCOSE METABOLISM USING ANTI-CGRP ANTIBODIES
#165Systems, apparatus, and methods for analyzing and predicting cellular pathways
#166METHOD OF DIFFERENTIATING MAMMALIAN PROGENITOR CELLS INTO INSULIN PRODUCING PANCREATIC ISLET CELLS
#167Neuroprotective chemicals and methods for identifying and using same
#168High MAST2-affinity polypeptides and uses thereof
#169Methods of diagnosing bipolar disorders and screening for therapeutic compounds
#170Metabolic flux biosensor
#171METHODS OF MANUFACTURING POLYSACCHARIDE COMPOSITIONS
#172Method for examining a plurality of cultured cells for the presence of periodic structures of at least one target component contained in the cultured cells
#173TECHNOLOGIES FOR MANUFACTURING AN ENGINEERED BIO-SYSTEM
#174Assay to evaluate drug metabolism
#175Genetically encoded probe for quantification of pyruvate concentration and methods of using the same
#176ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#177COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#178Preventive and therapeutic drug for cartilaginous hyperplasia and method of screening for the same
#179METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT
#180Method for selection of hDIS3 PIN domain inhibitors and use of hDIS3 PIN domain inhibitors for cancer treatment
#181Cell analysis apparatus and method
#182METHOD FOR SCREENING SKIN BARRIER FUNCTION ENHANCING AGENT BASED ON EPIDERMAL SERINE RACEMASE AND/OR D-SERINE LEVEL, AND SKIN BARRIER FUNCTION EVALUATION METHOD
#183Biological Materials and Uses Thereof
#184PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#185TLR8 TRANSGENIC ANIMALS
#186PHARMACEUTICAL PLATFORM TECHNOLOGY FOR THE DEVELOPMENT OF NATURAL PRODUCTS
#187Non-human animals having a humanized programmed cell death 1 gene
#188Heterocyclic compounds and methods of use thereof
#189Short term isotope pulse labeling method for analysing metabolic products in biological samples
#190Method of identifying or evaluating synergistic combinations of actives and compositions containing the same
#191Short-Term Infarction-Based Test for Investigative Drugs
#192Method of identifying or evaluating beneficial actives and compositions containing the same
#193MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#194Method for evaluating bioavailable zinc
#195In vitro pancreatic differentiation of pluripotent mammalian cells
#196Method for measuring carbohydrate metabolism ability, and composition for use in said method
#197METHODS FOR IDENTIFYING DIABETES DRUGS
#198METHODS FOR IDENTIFYING AGENTS FOR TREATING SMOOTH MUSCLE DISORDERS AND COMPOSITIONS THEREOF
#199Soluble MANF in pancreatic β-cell disorders
#200METHOD AND APPARATUS FOR DETERMINING DEGREE OF STRATIFICATION AND/OR DIFFERENTIATION
#201Toll-like receptors
#202Neuroprotective chemicals and methods for identifying and using same
#203METHOD OF SCREENING PHARMACEUTICALS FOR DRUG INTERACTIONS AND NEPHROTOXICITY
#204Genetically encoded probe for quantification of lactate and methods for quantifying metabolic rates and lactate transport
#205METHOD FOR IDENTIFYING DISEASE ASSOCIATED WITH ABUNDANCE OF TDP-43 IN CELL
#206NMR-based metabolite screening platform
#207Collateral gene inactivation biomarkers and targets for cancer therapy
#208CELL CULTURE LIQUID/GAS-PHASE CHAMBER DEVICES AND RELATED METHODS, AND EXEMPLARY USE FOR MEASURING ACCUMULATION OF GAS-PHASE NITRIC OXIDE IN DIFFERENTIATED CULTURES OF NORMAL AND CYSTIC FIBROSIS AIRWAY EPITHELIAL CELLS
#209Hyperspectral imaging for early detection of Alzheimer'S Disease
#210Detection of hydrogen peroxide
#211METHOD AND APPARATUS FOR CHEMICAL SENSING USING 2D PHOTONIC CRYSTAL ARRAYS
#212Selective glycosidase inhibitors and uses thereof
#213Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#214Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#215METHODS FOR DRUG DISCOVERY, DISEASE TREATMENT, AND DIAGNOSIS USING METABOLOMICS
#216Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
#217Method for evaluating human blastocyst by norepinephrine level in blastocyst culture solution
#218Methods and kits for measuring toxicity and oxidative stress in live cells
#219Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity
#220Methods of predicting crop yield using metabolic profiling
#221Cell analysis apparatus and method
#222Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#223Short-Term Surrogate Test for Investigative Drugs
#224Combination pharmaceuticals and methods thereof using proteinacious channels as treatments for medical conditions
#225Induced intercellular communication
#226Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass
#227Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
#228QUINOLINONE DERIVATIVES FOR USE IN THE TREATMENT OF AN AUTOIMMUNE DISEASE AND/OR AN INFLAMMATORY DISEASE
#229Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#230Store-operated calcium cellular assay
#231Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
#232Method of predicting crop yield using metabolic profiling
#233Method for real-time measurement of the individual secretions of a cell
#234Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
#235Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors
#236Detection of hydrogen peroxide
#237PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#238Transgenic mice expressing human toll-like receptor 8
#239Apparatus and Methods for Using Biological Material to Discriminate an Agent
#240Method of determining cell number or viability using hydroxyethyldisulfide
#241Biomarkers Related to Insulin Resistance and Methods using the Same
#242HMG-COA SECONDARY METABOLITES AND USES THEREOF
#243Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#244Methods for analyzing polar metabolites of the energy metabolism
#245CELL LINES EXPRESSING CFTR AND METHODS OF USING THEM
#246Cellular assay employing detectable protein
#247Polymorphism in CYP3A4 gene affecting drug metabolizing and uses thereof
#248METHODS OF USING RET NANOSENSORS
#249METABOLITES FOR ORAL HEALTH AND USES THEREOF
#250Process for the measurement of the potency of glatiramer acetate
#251DEVICE AND METHOD FOR NON-INVASIVE MEASUREMENT OF THE INDIVIDUAL METABOLIC RATE OF A SUBSTANTIALLY SPHERICAL METABOLIZING PARTICLE
#252Store-operated calcium cellular assay
#253Screening for compounds having immunosuppressant activity by testing impact on leukocyte-specific calcium fluxes
#254ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF
#255Method for generation and use of isotopic patterns in mass spectral data of simple organisms
#256Metabolic Biomarkers Of Drug-Induced Cardiotoxicity
#257Potentiators of insulin secretion
#258Method of measuring effects of components on cell reactive oxygen species production
#259Ex vivo cell stimulation
#260Method for generation and use of isotopic patterns in mass spectral data of simple organisms
#261Method of determining metabolism of a test agent
#262Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
#263Cell based screening assays for the triglyceride synthesis pathway
#264METHOD AND IMAGING MEDIUM FOR USE IN THE METHOD
#265UNDERCARBOXYLATED/UNCARBOXYLATED OSTEOCALCIN INCREASES BETA-CELL PROLIFERATION, INSULIN SECRETION, INSULIN SENSITIVITY, GLUCOSE TOLERANCE AND DECREASES FAT MASS
#266Method for screening essential metabolites in growth of microorganisms
#267Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
#268Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
#269GLYCOSYLTRANSFERASE ACTIVITY
#270YEAST PLATFORM CONSTRUCTION AND SCREENING METHODS
#271Ion channel assay methods
#272Method of treating depression
#273NATURAL SELECTION AND CELLULAR IMMORTALITY
#274Methods for identifying or assaying for agents that increase beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decrease fat mass
#275Method for Identiflying Modulators of Rufy2 Useful for Treating Alzheimer's Disease
#276Detection of HIV-1 infection
#277BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF
#278Apparatus and methods for monitoring the status of a metabolically active cell
#279IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
#280Mouse model and treatment of hereditary inclusion body myopathy
#281Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#282High-Throughput Cell-Based CFTR Assay
#283METHOD FOR RAPID IDENTIFICATION OF PHARMACOLOGICALLY ACTIVE CHEMICAL ENTITIES ASSOCIATED WITH THE EFFICACY OF ETHNOBOTANICAL SUBSTANCES
#284Increasing glucose transport and insulin-stimulated glucose uptake
#285Metabolic phenotyping
#286Generation and use of isotopic patterns in mass spectral phenotypic comparison of organisms
#287Modulation of line-1 reverse transcriptase
#288Mucopolysaccharidosis (MPS) diagnostic methods, systems, kits and assays associated therewith
#289Device and methods for monitoring the status of at least one cell
#290Method for identifying modulators of NOAH10 useful for treating Alzheimer's disease
#291Process for the measurement of the potency of glatiramer acetate
#292Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer's Disease
#293Method for generation and use of isotopic patterns in mass spectral data of simple organisms
#294Modulation of line-1 reverse transcriptase
#295Compositions and methods for promoting lipid mobilization in humans
#296Attractin/mahogany-like polypeptides
#297Delta-9-tetrahydrocannabinol detection method
#298METHODS FOR DRUG DISCOVERY, DISEASE TREATMENT, AND DIAGNOSIS USING METABOLOMICS
#299Method for Predicting the Metabolism of Drug in Human Liver and Liver Function
#300Biomarkers of Ionizing Radiation Response